Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Public Health / 公共衛生學院
  3. Epidemiology and Preventive Medicine / 流行病學與預防醫學研究所
  4. Evolutionary trajectories and genomic divergence in localized breast cancers after ipsilateral breast tumor recurrence
 
  • Details

Evolutionary trajectories and genomic divergence in localized breast cancers after ipsilateral breast tumor recurrence

Journal
Cancers
Journal Volume
13
Journal Issue
8
Date Issued
2021
Author(s)
Wu C.-H.
Yeh H.-T.
Hsieh C.-S.
Huang C.-C.
Amrita Chattopadhyay  
Chung Y.-C.
Tu S.-H.
Li Y.-H.
TZU-PIN LU  
LIANG-CHUAN LAI  
Hou M.-F.
KING-JEN CHANG  
MONG-HSUN TSAI  
ERIC YAO-YU CHUANG  
DOI
10.3390/cancers13081821
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103843246&doi=10.3390%2fcancers13081821&partnerID=40&md5=9e69d9e3272ab0a5dfb82cefc6429710
https://scholars.lib.ntu.edu.tw/handle/123456789/561613
Abstract
The evolutionary trajectories that drive clinical and therapeutic consequences in localized breast cancers (BCs) with ipsilateral breast tumor relapse (IBTR) remain largely unknown. Analyses of longitudinal paired whole-exome sequencing data from 10 localized BC patients with IBTR reveal that, compared to primary breast tumors, homologous recombination (HR) deficiency, inactivation of the HR pathway, chromosomal instability, and somatic driver mutations are more frequent. Furthermore, three major models of evolution in IBTR are summarized, through which relative contributions of mutational signatures shift, and the subclonal diversity expansions are shown. Optimal treatment regimens are suggested by the clinically relevant molecular features, such as HR deficiency (20%) or specific alterations (30%) with sensitivity to available FDA-approved drugs. Finally, a rationale for the development of the therapeutic management framework is provided. This study sheds light on the complicated evolution patterns in IBTR and has significant clinical implications for future improvement of treatment decisions. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Subjects
Actionability; Alteration; Clonal architecture; Ipsilateral breast tumor relapse; Whole-exome sequencing
SDGs

[SDGs]SDG3

Other Subjects
tumor marker; adult; aged; algorithm; Article; breast cancer; cancer growth; cancer localization; cancer recurrence; chromosomal instability; clinical article; clinical feature; cohort analysis; evolution; genetic variability; homologous recombination; human; human epidermal growth factor receptor 2 positive breast cancer; human tissue; ipsilateral breast tumor relapse; middle aged; molecular cloning; sensitivity analysis; somatic mutation; triple negative breast cancer
Publisher
MDPI AG
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science